| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.5M | -3.8% |
| R&D Expense | $118.9M | +12.2% |
| SG&A Expense | $109.1M | -41.0% |
| Operating Income | -$179.5M | +20.8% |
| Interest Expense | $56.8M | +22.6% |
| Income Tax | $0 | — |
| Net Income | -$233.7M | +13.2% |
| EPS (Basic) | -$3.52 | +62.2% |
| EPS (Diluted) | -$3.52 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.8M | -40.3% |
| Short-term Investments | $42.1M | -16.6% |
| Accounts Receivable | $33.7M | +47.1% |
| Inventory | $35.2M | +2.3% |
| Current Assets | $246.7M | -25.0% |
| Total Assets | $247.9M | -35.0% |
| Current Liabilities | $92.3M | +25.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$174.8M | +33.7% |
| Investing Cash Flow | $8.1M | +116.1% |
| Financing Cash Flow | $32.6M | -87.8% |
| +62.2% |
| Total Liabilities |
| $571.7M |
| -1.2% |
| Stockholders' Equity | -$323.8M | -64.4% |